Healthcare [ 13/13 ] | Biotechnology [ 127/164 ]
NASDAQ | Common Stock
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States.
It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.
The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021.
HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 5, 24 | 0.00 Increased by +100.00% | -0.89 Increased by +100.00% |
| Mar 15, 24 | 0.00 Increased by +100.00% | -0.82 Increased by +100.00% |
| Nov 9, 23 | -0.81 Decreased by -80.00% | -0.84 Increased by +3.57% |
| Aug 14, 23 | -0.74 Increased by +63.55% | -0.90 Increased by +17.78% |
| May 12, 23 | -0.71 Increased by +92.94% | -0.94 Increased by +24.47% |
| Mar 17, 23 | -0.56 Increased by +91.94% | -1.46 Increased by +61.64% |
| Nov 10, 22 | -0.45 Increased by +78.16% | -0.91 Increased by +50.55% |
| Aug 10, 22 | -2.03 | -0.78 Decreased by -160.26% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | -31.82 M Decreased by -105.09% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -27.90 M Increased by +70.64% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -24.01 M Increased by +80.38% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -19.28 M Increased by +48.36% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -15.51 M Increased by +74.93% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -95.05 M Decreased by -5.60 K% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -122.40 M Decreased by -7.82 K% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -37.33 M Decreased by N/A% | Decreased by N/A% - |